Changing Systems, One Story at a Time: National Summit Reimagines Obesity Care Through Community, Connection, and Compassion
With the theme "Inspire Change. Build Connection. Advance Wellness.", the summit brings together healthcare professionals, lived experience advocates, and community leaders to explore how we can shift the narrative around health — from judgment to empathy, and from isolation to meaningful support.
"Obesity isn't a character flaw — it's a chronic condition that deserves empathy, science, and dignity," says Priti Chawla, Executive Director of Obesity Matters.
"This summit is about rewriting the narrative — one story, one connection, one person at a time."
Program highlights include:
Dr. Sean Wharton and Dr. Gillian Mandich on self-compassion and emotional resilience
Dr. Megha Poddar on hormone health across life stages
Dr. Peter Selby facilitating a storytelling session with patient advocates
Dr. David Macklin on Resilience… The Secret Skill to Success
A featured session on Body Image, Stigma, and the Age of Anti-Obesity Medication will be led by Dr. Sandy Van and Sandra Elia, Chair of Obesity Matters.
"We can't let outdated ideals or social media define what health looks like," says Dr. Sandy Van.
"In the era of obesity medication, the pressure to meet unrealistic appearance goals can take a real psychological toll. Effective care must be rooted in evidence, with compassion for both the body and the mind."
"For too long, people have carried the weight of shame when what they needed was care. At this summit, we are rewriting that story — one rooted in love, science, and the belief that every person deserves access to evidence-based treatment." — Sandra Elia, Chair, Obesity Matters
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
an hour ago
- Cision Canada
FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2025: U.S. POINTER STUDY SHOWS STRUCTURED LIFESTYLE PROGRAM TARGETING MULTIPLE RISK FACTORS IMPROVES COGNITION IN OLDER ADULTS AT RISK OF COGNITIVE DECLINE
Key Takeaways Two lifestyle interventions in U.S. POINTER improved cognition in older adults at risk of cognitive decline. A structured intervention with more support and accountability showed greater improvement compared to a self-guided intervention. In a large, representative group of older adults at high risk for cognitive decline, multidomain lifestyle interventions were delivered with high adherence and safety. Cognitive benefits were consistent across age, sex, ethnicity, heart health status and apolipoprotein E-e4 genotype. TORONTO, July 28, 2025 /CNW/ -- The Alzheimer's Association U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) — a two-year, multi-site clinical trial testing two different lifestyle interventions in a representative population of older adults at risk for cognitive decline and dementia — found that both interventions improved cognition in older adults at risk of cognitive decline. Trial participants in the structured (STR) intervention showed greater improvement on global cognition compared to the self-guided (SG) intervention, protecting cognition from normal age-related decline for up to two years. The STR intervention differed from the SG intervention in intensity, structure, accountability and support provided. The results were reported for the first time today at the Alzheimer's Association International Conference (AAIC) 2025 in Toronto and online. "Effects Of Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The U.S. POINTER Randomized Clinical Trial," was published in The Journal of the American Medical Association (JAMA) simultaneously with the report at AAIC 2025. U.S. POINTER is the first large-scale, randomized controlled clinical trial to demonstrate that an accessible and sustainable healthy lifestyle intervention can protect cognitive function in diverse populations in communities across the United States. "As the burden of dementia grows world-wide, U.S. POINTER affirms a vital public health message: healthy behavior has a powerful impact on brain health," said Joanne Pike, DrPH, Alzheimer's Association president and CEO. "This is a critical public health opportunity. The intervention was effective across a broad, representative group — regardless of sex, ethnicity, APOE genetic risk, or heart health status — demonstrating its applicability and scalability for communities across the country," said Pike. "The positive results of U.S. POINTER encourage us to look at the potential for a combination of a lifestyle program and drug treatment as the next frontier in our fight against cognitive decline and possibly dementia." U.S. POINTER leadership acknowledges participants, their family members and study site staff for their unique and essential contributions: "You helped change what we know about brain health. Thanks to your dedication, time and support, U.S. POINTER delivered groundbreaking results. Your children, grandchildren and generations to come will benefit from the commitment you made." Both interventions focused on physical exercise, nutrition, cognitive challenge and social engagement, and heart health monitoring, but differed in intensity, structure, accountability and support provided. Structured lifestyle intervention. Participants attended 38 facilitated peer team meetings over two years, and were provided with a prescribed activity program with measurable goals for: aerobic, resistance and stretching exercise; adherence to the MIND diet; cognitive challenge through BrainHQ training and other intellectual and social activities; and regular review of health metrics and goal-setting with a study clinician. Self-guided lifestyle intervention. Participants attended six peer team meetings to encourage self-selected lifestyle changes that best fit their needs and schedules. Study staff provided general encouragement without goal-directed coaching. "The potential to improve cognition with fewer resources and lower participant burden is compelling. It highlights that while not everyone has the same access or ability to adhere to more intensive behavior interventions, even modest changes may protect the brain," said Laura D. Baker, Ph.D., Professor of Gerontology and Geriatrics, and Internal Medicine, at Wake Forest University School of Medicine and Advocate Health, and U.S. POINTER principal investigator. "These are the initial results. Over the coming weeks and months, study leadership will be exploring all of the data collected in the trial to paint an even more comprehensive picture of the U.S. POINTER intervention effects on brain health," Baker said. People with cognitive decline and dementia often have a variety of damaging changes in their brain. This means effective treatment will likely require a multi-pronged or combination strategy to address multiple disease mechanisms. "Complex diseases like heart disease and cancer use combination treatment strategies tailored to individual characteristics. The next generation of treatments for diseases like Alzheimer's will likely integrate drug and non-drug strategies. U.S. POINTER provides a strong foundation for such combination approaches," said Heather M. Snyder, Ph.D., Alzheimer's Association study primary investigator and senior vice president of medical and scientific relations. "While these results are fascinating and extremely hopeful, how they are rolled out to the public — especially those at risk for Alzheimer's and other diseases that cause dementia — needs to be handled with care and individual attention to tailor to the local environment," said Snyder. The Alzheimer's Association has invested nearly $50 million to lead this study to date, with additional support from the National Institute on Aging at the National Institutes of Health for add-on studies exploring imaging, vascular measures, sleep and gut microbiome-related health data. In addition to its investments to date, the Alzheimer's Association will invest more than $40 million over the next four years to continue to follow U.S. POINTER participants, and to bring U.S. POINTER interventions to communities across America. U.S. POINTER is a phase 3, five-site, two-year, single-blind randomized clinical trial of two lifestyle interventions in older adults at risk for dementia. U.S. POINTER was developed to assess whether the results of the FINGER study [ Lancet, 6-6-15] generalize to a larger, more diverse U.S. population at risk for cognitive decline and dementia, using culturally adapted protocols. The primary aim was to compare the effects of two multimodal lifestyle interventions on global cognitive function in 2,000+ at-risk older adults. Secondary aims assessed intervention effects on specific cognitive domains, and potential differences based on baseline cognition, sex, age, APOE-e4 genotype, and cardiovascular risk. The study was conducted at five geographically dispersed U.S. academic centers and health care systems in partnership with the Alzheimer's Association. Participant eligibility criteria were designed to enrich the risk of cognitive decline and included older age (60-79 years), sedentary lifestyle, suboptimal diet and cardiometabolic health, and family history of memory impairment. 2,111 participants were enrolled and randomized to STR (n=1,056) or SG (n=1,055). Mean age was 68.2 years, 68.9% were female, 30.8% were from ethnoracial minority groups. Seventy-eight percent (78%) reported a first-degree family history of memory loss, and 30% were APOE-e4 carriers. Retention was high, with 89% completing the final 2 year assessment. At two years, there was a statistically significant intervention group difference on the primary outcome. Global cognitive composite scores (primary outcome) increased over time in both groups but the improvement over time was statistically significant for a greater benefit for the STR versus SG: 0.029 SD per year (95% CI, 0.008-0.050, P =0.008). For secondary outcomes, the increase in executive function z-score was greater in STR than SG by 0.037 SD per year (95% CI, 0.010-0.064). Processing speed showed a similar trend but was not statistically significant. There were no group differences in memory. Looking ahead, the Association will build on the momentum of U.S. POINTER by launching several programs and initiatives, including: A personal brain health assessment tool. A virtual brain health training program for health care providers. A community recognition program for organizations championing brain health. A brain health roundtable that will unite leaders across health care, public health, community and corporate sectors to accelerate impact. About AAIC AAIC is the world's largest gathering of researchers from around the world focused on Alzheimer's and other diseases that cause dementia. As a part of the Alzheimer's Association's research program, AAIC serves as a catalyst for generating new knowledge about dementia and fostering a vital, collegial research community. AAIC 2025: AAIC 2025 newsroom: AAIC 2025 hashtag: #AAIC25 About the Alzheimer's Association The Alzheimer's Association is a worldwide voluntary health organization dedicated to Alzheimer's care, support and research. Our mission is to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. Visit or call +1 800.272.3900.
Cision Canada
an hour ago
- Cision Canada
Wake Up Talks Coaching Launches Strategic Coaching Pathway to Help Introverted Midlife Women Reclaim Clarity and Confidence
The 12-week Authentic Self-Empowerment Framework offers a proven, structured method for introverted professional women to overcome internal stress, rediscover their purpose NEW YORK, July 28, 2025 /CNW/ -- Wake Up Talks Coaching, founded by accredited coach and former business strategist Simona Zajc, has officially launched the Authentic Self-Empowerment Pathway, a private, 12-week coaching experience specifically designed to support introverted professional women in midlife navigating emotional overwhelm, self-doubt, and transitions in identity or purpose. Simona, an ICF and EMCC certified coach, developed Strategic Mind Method to meet a widespread yet often unspoken need: the internal struggle many midlife women face as they quietly juggle professional responsibilities, family dynamics, and their own unmet aspirations. Unlike generalized life coaching, this program provides a structured, step-by-step process that supports personal clarity, calm, and actionable change from the inside out adhering to firm coaching standards. "As a former strategist turned coach, I've seen how many women silently struggle, questioning their direction while maintaining an outward calm," says Zajc. "This program meets them where they are—with tools that help shift the pressure and unlock clear, confident action." The need for such targeted coaching is backed by research: 47% of midlife women identify as introverts, making them more prone to internalized stress. Studies by Phoenix Insights and Ipsos, published in Actuarial Post, reveal that over 50% of women aged 45–55 feel "stuck" or unsure about how to move forward in life or career. Past clients of the program report a 50% increase in mental clarity, a 33% rise in calm, and significantly improved decision-making confidence. Each week of the program builds on the last, using private coaching, deep listening, and introspective exercises to guide participants toward self-awareness, values-based decision-making, and sustainable personal growth. By the end of 12 weeks, clients are equipped not only with insight but with actionable strategies to navigate their next chapter with renewed confidence. Enrollment is now open, with only five client spots available per month to ensure personalized support. Visit to learn more. Founded by Simona Zajc—ICF/EMCC-certified coach, former business strategist, and award-winning author— Wake Up Talks Coaching specializes in helping introverted midlife women overcome overwhelm and rediscover their authentic path. Through her signature Authentic Self-Empowerment Pathway, Simona offers structured, high-touch coaching for lasting clarity, calm, and confidence.
Cision Canada
4 hours ago
- Cision Canada
Saskatchewan Blue Cross supports high-risk communities with $50,000 for equipment for screening chronic kidney disease
SASKATOON, SK , July 28, 2025 /CNW/ - In Saskatchewan, ten per cent of the population lives with a form of kidney disease. Over the last ten years, the number of individuals with kidney disease requiring dialysis has increased by 50 per cent. Chronic Kidney Disease, or CKD, is frequently called the "silent killer", as it can progress without obvious symptoms until it's too late. Individuals diagnosed with chronic kidney failure must visit a dialysis centre three to four times a week, with each visit lasting up to four hours until transplant or end of life. For a family near a city centre, this unrelenting schedule can be challenging. For families in rural Saskatchewan, the diagnosis can be devastating – often resulting in hours of travel or having to leave their communities to be closer to care. Those residing in Northern Saskatchewan are uniquely susceptible to CKD, with access to care and the genetic predisposition of the disease among Indigenous peoples being distressing factors in the increased rate of CKD. The disease also increases the risk of other life-threatening conditions, such as heart disease, stroke, diabetes and limb amputations. Through a shared vision with the Ministry of Health and the Saskatchewan Health Authority, St. Paul's Hospital Foundation are working together on prevention and early treatment with the By Your Side Kidney Care Campaign. The campaign supports better patient-centred modalities of care that improve their experience, autonomy and outcomes during treatment. This includes new programs, centres and support for those at risk or facing CKD. The By Your Side Kidney Care Campaign is a critical initiative to change these devastating, preventable outcomes. Its three priorities are access to care and education, holistic care and proactive prevention. The main priority is the Early Screening Program, which provides individuals, particularly in high-risk communities, with access to early detection and education. "At Saskatchewan Blue Cross, we believe access to early detection and education can change lives," said Kelly Wilson, President and CEO of Saskatchewan Blue Cross. "Our $50,000 commitment to St. Paul's Hospital Foundation's 'By Your Side Kidney Care Campaign' reflects our dedication to improving health outcomes in Saskatchewan, especially in high-risk and underserved communities. We hope others are equally motivated to support the Early Screening Program for Chronic Kidney Disease, bringing much-needed care and hope to individuals and families across the province." This critical funding from Saskatchewan Blue Cross supports purchasing vital equipment required for screening CKD. It also promotes the gathering of vital data that will help lay the foundation for a sustainable early diagnosis system in at-risk communities. "We are deeply grateful to Saskatchewan Blue Cross for their generous support of the By Your Side Kidney Health Campaign and the Early Screening Program," said Lecina Hicke, CEO of St. Paul's Hospital Foundation. "Their partnership is helping to close critical gaps in care by creating access to early detection and education in underserved and remote communities. Together, we are working to build a stronger, more equitable healthcare system that ensures everyone has access to the care they need, when they need it most." The equipment is just the beginning. St. Paul's Hospital Foundation is committed to raising $10 million for the By Your Side Kidney Care Campaign. Their hope is to create patient-centred and holistic health initiatives that save lives, while reducing the economic and social impacts of early-onset kidney failure. Learn more about the campaign and donate by visiting the St. Paul's Hospital Foundation website
